MANAGEMENT OF MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) or Metabolic-associated fatty liver disease (MAFLD), has become the most common chronic liver disease, and its prevalence will likely continue to rise. Dr Ross Apostolov, a gastroenterologist and hepatologist, has provided a summary of the The EASL–EASD–EASO Clinical Practice Guidelines on the management of MASLD, which were published late […] Read more...